{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T14:44:22Z","timestamp":1773240262103,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"21-22","license":[{"start":{"date-parts":[[2011,8,15]],"date-time":"2011-08-15T00:00:00Z","timestamp":1313366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00508-011-0034-8","type":"journal-article","created":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T08:56:28Z","timestamp":1313052988000},"page":"684-687","source":"Crossref","is-referenced-by-count":1,"title":["The 5-year follow-up of a cortical stress fracture resulting in a spontaneous atypical subtrochanteric femoral fracture in a female patient with severe osteoporosis and bisphosphonate therapy over 15 years","Die kortikale Stressfraktur als Prodromalstadium einer atypischen subtrochant\u00e4ren Fraktur nach 15-j\u00e4hriger Bisphosphonattherapie einer Patientin mit Osteoporose"],"prefix":"10.1007","volume":"123","author":[{"given":"Judith","family":"Haschka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friederike","family":"K\u00fchne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Muschitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Pirker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Kocijan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Bittighofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Trubrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Resch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,15]]},"reference":[{"issue":"11","key":"34_CR1","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1002\/jbmr.253","volume":"25","author":"E Shane","year":"2010","unstructured":"Shane E, Burr D, Ebeling PR, Abrahamsen B, Adler RA, et al. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research. American Society for Bone and Mineral Research. J Bone Miner Res 2010;25(11):2267\u201394","journal-title":"J Bone Miner Res"},{"key":"34_CR2","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","volume":"364","author":"J Schilcher","year":"2011","unstructured":"Schilcher J, Micha\u00eblsson K, Aspenberg P. Bisphosphonate Use and Atypical Fractures of the Femoral Shaft. N Engl J Med 2011;364:1728\u201337","journal-title":"N Engl J Med"},{"issue":"19","key":"34_CR3","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1056\/NEJMoa1001086","volume":"362","author":"DM Black","year":"2010","unstructured":"Black DM, Kelly MP, Genant HK, Palermo L, Eastell R, Bucci-Rechtweg C, Cauley J, Leung PC, Boonen S, Santora A, de Papp A, Bauer DC. Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur. Fracture Intervention Trial Steering Committee; HORIZON Pivotal Fracture Trial Steering Committee. N Engl J Med 2010;13;362(19):1761\u201371","journal-title":"N Engl J Med"},{"issue":"8","key":"34_CR4","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","volume":"20","author":"BA Lenart","year":"2009","unstructured":"Lenart BA, Neviaser AS, Lyman S, Chang CC, Edobor-Osula F, Steele B, van der Meulen MC, Lorich DG, Lane JM. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study. Osteoporos Int 2009;20(8):1353\u201362","journal-title":"Osteoporos Int"},{"issue":"12","key":"34_CR5","doi-asserted-by":"crossref","first-page":"5258","DOI":"10.1210\/jc.2010-1571","volume":"95","author":"B Abrahamsen","year":"2010","unstructured":"Abrahamsen B, Eiken P, Eastell R. Cumulative alendronate dose and the long-term absolute risk of subtrochanteric and diaphyseal femur fractures: a register-based national cohort analysis. J Clin Endocrinol Metab 2010;95(12):5258\u201365","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"34_CR6","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1359\/jbmr.090731","volume":"25","author":"P Aspenberg","year":"2010","unstructured":"Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, Garc\u00eda-Hern\u00e1ndez PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 2010;25(2):404\u201314","journal-title":"J Bone Miner Res"},{"issue":"22","key":"34_CR7","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman UA, Weiss SR, Br\u00f6ll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 1995;333(22):1437\u201343","journal-title":"N Engl J Med"},{"key":"34_CR8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2106\/JBJS.D.02115","volume":"87","author":"YM lkhiary","year":"2005","unstructured":"lkhiary YM, Gerstenfeld LC, Krall E, et al. Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1\u201334). J Bone Joint Surg Am 2005;87:731\u201341","journal-title":"J Bone Joint Surg Am"}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-011-0034-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00508-011-0034-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-011-0034-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T01:53:25Z","timestamp":1559094805000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00508-011-0034-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,15]]},"references-count":8,"journal-issue":{"issue":"21-22","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["34"],"URL":"https:\/\/doi.org\/10.1007\/s00508-011-0034-8","relation":{},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,15]]}}}